New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?

Citation
La. Tintignac et al., New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?, B CANCER, 88(6), 2001, pp. 545-548
Citations number
30
Categorie Soggetti
Oncology
Journal title
BULLETIN DU CANCER
ISSN journal
00074551 → ACNP
Volume
88
Issue
6
Year of publication
2001
Pages
545 - 548
Database
ISI
SICI code
0007-4551(200106)88:6<545:NIIMRI>2.0.ZU;2-J
Abstract
The transcription factor MyoD, member of the myogenic regulators family, in duced differentiation in precursor cells by its ability to arrest cell prol iferation and to activate muscle specific genes. MyoD plays a key role in t he antagonism between proliferation and to activate muscle specific genes. MyoD plays a key role in the antagonism between proliferation and different iation. The withdrawal from the cell cycle and the activation of muscle dif ferentiation are related to the level of MyoD protein. The cyclin E-cdk2 co mplex, one of the key regulators of the G1/S transition is directly implica ted in the degradation of MyoD by the ubiquitin-proteasome pathway, leading the myoblasts to proliferate. The display of this control in normal myobla sts suggest that its deficiency in the muscle stem cells could lead to the formation of rhabdomyosarcomas which have lost both the control of cell pro liferation and the transcriptional activity of MyoD.